Oxymetholone , ≥98% , 434-07-1
Synonym(s):
17β-Hydroxy-2-(hydroxymethylene)-17-methyl-5α-androstan-3-one;Anasterone
CAS NO.：434-07-1
Empirical Formula: C21H32O3
Molecular Weight: 332.48
MDL number: MFCD00869395
EINECS: 207-098-6
| Pack Size | Price | Stock | Quantity |
| 1G | RMB168.80 | In Stock |
|
| 5G | RMB600.00 | In Stock |
|
| 25G | RMB1560.80 | In Stock |
|
| others | Enquire |
PRODUCT Properties
| Melting point: | 172-180°C |
| alpha | 34 º |
| Boiling point: | 409.59°C (rough estimate) |
| Density | 1.0834 (rough estimate) |
| refractive index | 38 ° (C=1, CHCl3) |
| storage temp. | 2-8°C |
| solubility | H2O: ≤0.5 mg/mL |
| form | solid |
| pka | 5.28±0.70(Predicted) |
| color | white to light yellow |
| Water Solubility | <0.1 g/100 mL at 23 ºC |
| Merck | 6967 |
| Stability: | Stability May be light sensitive. Combustible. Incompatible with strong oxidizing agents. |
| InChIKey | ICMWWNHDUZJFDW-CCTJMHFWSA-N |
| CAS DataBase Reference | 434-07-1(CAS DataBase Reference) |
| NIST Chemistry Reference | Oxymetholone(434-07-1) |
| EPA Substance Registry System | Oxymetholone (434-07-1) |
Description and Uses
Oxymetholone is a synthetic, orally active anabolic-androgenic steroid (AAS) and 17α-methylated derivative of dihydrotestosterone (DHT). It is mainly used for the treatment of osteroporosis and anemia (low red blood cell count). It can also stimulate the muscle growth in malnourished or underdeveloped patients. It also has the potential to treat the HIV wasting syndrome. Oxymetholone can also lead to an even buildup in strength, which is its secondary characteristics, making it an excellent steroid to be coupled with other anabolic steroids to yield synergetic effect.
Oxymetholone is used in treatment of myelofibrosis and myelosuppression. This drug can provoke bone marrow cells and rise the blood cells in the peripheral blood vessels. It has been approved by the US Food and Drug Administration for the treatment of anemia caused by deficient red cell production. It is effective in catabolic states, replacement of male sex steroids in men who have androgen deficiency, and in eugonadal male and female patients with acquired immunodeficiency syndrome-associated wasting.
Safety
| Symbol(GHS) |  GHS08 |
| Signal word | Warning |
| Hazard statements | H351-H361 |
| Precautionary statements | P201-P308+P313 |
| Hazard Codes | T,Xn |
| Risk Statements | 40-63 |
| Safety Statements | 53-22-26-36/37/39-36 |
| WGK Germany | 3 |
| RTECS | BV8060000 |
| HS Code | 29372900 |
| Hazardous Substances Data | 434-07-1(Hazardous Substances Data) |
| Toxicity | TDLo orl-hmn: 46 mg/kg/14W-I:LIV JAMAAP 240,243,78 |
